centene corp. - CNC
CNC
Close Chg Chg %
60.06 -0.16 -0.26%
Open Market
59.91
-0.16 (0.26%)
Volume: 1.97M
Last Updated:
Dec 3, 2024, 12:15 PM EDT
Company Overview: centene corp. - CNC
CNC Key Data
| Open $60.23 | Day Range 58.88 - 60.27 |
| 52 Week Range 57.25 - 81.42 | Market Cap $30.32B |
| Shares Outstanding 504.87M | Public Float 499.37M |
| Beta 0.46 | Rev. Per Employee N/A |
| P/E Ratio 10.42 | EPS $5.79 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 5.91M |
CNC Performance
| 1 Week | 0.10% | ||
| 1 Month | -5.45% | ||
| 3 Months | -15.21% | ||
| 1 Year | -19.79% | ||
| 5 Years | -1.51% |
CNC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
21
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 81.067 | |
| Number of Ratings | 21 | Current Quarters Estimate | 0.461 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 6.724 | |
| Last Quarter’s Earnings | 1.62 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 6.68 | Next Fiscal Year Estimate | 7.118 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 17 | 14 | 18 | 18 |
| Mean Estimate | 0.46 | 2.32 | 6.72 | 7.12 |
| High Estimates | 0.71 | 2.72 | 7.00 | 8.00 |
| Low Estimate | -0.22 | 2.04 | 4.99 | 5.58 |
| Coefficient of Variance | 40.52 | 8.96 | 6.50 | 6.54 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 9 | 9 | 7 |
| OVERWEIGHT | 2 | 3 | 4 |
| HOLD | 10 | 10 | 9 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Centene Corp. - CNC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Centene Corp. - CNC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jul 8, 2024 | Kenneth J. Fasola President | 286,066 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $66.76 per share | 19,097,766.16 |
| Jul 3, 2024 | Christopher J. Coughlin Director | 25,956 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 3, 2024 | Frederick H. Eppinger Director | 351,450 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 3, 2024 | Wayne S. DeVeydt Director | 13,827 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 3, 2024 | Kenneth A. Burdick Director | 361,519 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 3, 2024 | Theodore Rapp Samuels Director | 13,288 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Sarah McGinty London Chief Executive Officer; Director | 711,677 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.93 per share | 48,344,218.61 |
| Jun 25, 2024 | Christopher A. Koster Secretary & General Counsel | 196,734 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.93 per share | 13,364,140.62 |
| Jun 19, 2024 | Susan Smith Chief Operating Officer | 60,839 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $68.93 per share | 4,193,632.27 |
| May 17, 2024 | Monte E. Ford Director | 7,256 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 17, 2024 | H. James Dallas Director | 40,303 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 17, 2024 | Lori J. Robinson Director | 14,371 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 17, 2024 | Jessica L. Blume Director | 24,786 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 9, 2024 | Andrew Lynn Asher Chief Financial Officer | 469,647 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $75.14 per share | 35,289,275.58 |
| Mar 20, 2024 | Katie Casso Corporate Controller & CAO | 50,105 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $76.05 per share | 3,810,485.25 |
| Mar 20, 2024 | Christopher A. Koster Secretary & General Counsel | 198,687 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 20, 2024 | Sarah McGinty London Chief Executive Officer; Director | 713,664 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 20, 2024 | Andrew Lynn Asher Chief Financial Officer | 480,844 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 20, 2024 | Katie Casso Corporate Controller & CAO | 61,939 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 20, 2024 | Kenneth J. Fasola President | 308,357 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Centene Corp. in the News
Companies thought they had a plan for fall, now they are scrapping it
The swift, startling resurgence of Covid-19 cases and hospitalizations across the U.S. is causing corporate leaders to rip up playbooks for the next few months.